184 related articles for article (PubMed ID: 36052535)
1. A cohesin-associated gene score may predict immune checkpoint blockade in hepatocellular carcinoma.
Liu CZ; Li JD; Chen G; He RQ; Lin R; Huang ZG; Li JJ; Du XF; Lv XP
FEBS Open Bio; 2022 Oct; 12(10):1857-1874. PubMed ID: 36052535
[TBL] [Abstract][Full Text] [Related]
2. Distinct and overlapping roles of STAG1 and STAG2 in cohesin localization and gene expression in embryonic stem cells.
Arruda NL; Carico ZM; Justice M; Liu YF; Zhou J; Stefan HC; Dowen JM
Epigenetics Chromatin; 2020 Aug; 13(1):32. PubMed ID: 32778134
[TBL] [Abstract][Full Text] [Related]
3. Redundant and specific roles of cohesin STAG subunits in chromatin looping and transcriptional control.
Casa V; Moronta Gines M; Gade Gusmao E; Slotman JA; Zirkel A; Josipovic N; Oole E; van IJcken WFJ; Houtsmuller AB; Papantonis A; Wendt KS
Genome Res; 2020 Apr; 30(4):515-527. PubMed ID: 32253279
[TBL] [Abstract][Full Text] [Related]
4. Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5.
Xu R; Lin L; Zhang B; Wang J; Zhao F; Liu X; Li Y; Li Y
BMC Cancer; 2021 Jun; 21(1):687. PubMed ID: 34112092
[TBL] [Abstract][Full Text] [Related]
5. STAG1 vulnerabilities for exploiting cohesin synthetic lethality in STAG2-deficient cancers.
van der Lelij P; Newman JA; Lieb S; Jude J; Katis V; Hoffmann T; Hinterndorfer M; Bader G; Kraut N; Pearson MA; Peters JM; Zuber J; Gileadi O; Petronczki M
Life Sci Alliance; 2020 Jul; 3(7):. PubMed ID: 32467316
[TBL] [Abstract][Full Text] [Related]
6. PDS5A and PDS5B differentially affect gene expression without altering cohesin localization across the genome.
Arruda NL; Bryan AF; Dowen JM
Epigenetics Chromatin; 2022 Aug; 15(1):30. PubMed ID: 35986423
[TBL] [Abstract][Full Text] [Related]
7. Cohesin Members Stag1 and Stag2 Display Distinct Roles in Chromatin Accessibility and Topological Control of HSC Self-Renewal and Differentiation.
Viny AD; Bowman RL; Liu Y; Lavallée VP; Eisman SE; Xiao W; Durham BH; Navitski A; Park J; Braunstein S; Alija B; Karzai A; Csete IS; Witkin M; Azizi E; Baslan T; Ott CJ; Pe'er D; Dekker J; Koche R; Levine RL
Cell Stem Cell; 2019 Nov; 25(5):682-696.e8. PubMed ID: 31495782
[TBL] [Abstract][Full Text] [Related]
8. Cohesin mutations in human cancer.
Hill VK; Kim JS; Waldman T
Biochim Biophys Acta; 2016 Aug; 1866(1):1-11. PubMed ID: 27207471
[TBL] [Abstract][Full Text] [Related]
9. Synthetic lethality between the cohesin subunits
van der Lelij P; Lieb S; Jude J; Wutz G; Santos CP; Falkenberg K; Schlattl A; Ban J; Schwentner R; Hoffmann T; Kovar H; Real FX; Waldman T; Pearson MA; Kraut N; Peters JM; Zuber J; Petronczki M
Elife; 2017 Jul; 6():. PubMed ID: 28691904
[TBL] [Abstract][Full Text] [Related]
10. A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma.
Luo Y; Liu H; Fu H; Ding GS; Teng F
Front Immunol; 2022; 13():974377. PubMed ID: 36458010
[TBL] [Abstract][Full Text] [Related]
11. Specialized functions of cohesins STAG1 and STAG2 in 3D genome architecture.
Cuadrado A; Losada A
Curr Opin Genet Dev; 2020 Apr; 61():9-16. PubMed ID: 32294612
[TBL] [Abstract][Full Text] [Related]
12. An Unfolded Protein Response-Related mRNA Signature Predicting the Survival and Therapeutic Effect of Hepatocellular Carcinoma.
Su Z; Wang L; Chen X; Zhong X; Wang D; Wang J; Shao L; Chen G; Wu J
Comb Chem High Throughput Screen; 2022; 25(12):2046-2058. PubMed ID: 35125080
[TBL] [Abstract][Full Text] [Related]
13. Cohesin subunits, STAG1 and STAG2, and cohesin regulatory factor, PDS5b, in oral squamous cells carcinomas.
França JA; Diniz MG; Bernardes VF; Costa-Silva RC; Souza RP; Gomez RS; Gomes CC
J Oral Pathol Med; 2017 Mar; 46(3):188-193. PubMed ID: 27341316
[TBL] [Abstract][Full Text] [Related]
14. Serine Protease Inhibitor Kazal Type 1, A Potential Biomarker for the Early Detection, Targeting, and Prediction of Response to Immune Checkpoint Blockade Therapies in Hepatocellular Carcinoma.
Jia J; Ga L; Liu Y; Yang Z; Wang Y; Guo X; Ma R; Liu R; Li T; Tang Z; Wang J
Front Immunol; 2022; 13():923031. PubMed ID: 35924241
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of
Bai L; Ren Y; Cui T
J Comput Biol; 2020 Jun; 27(6):965-974. PubMed ID: 31593490
[TBL] [Abstract][Full Text] [Related]
16. Immune-related long noncoding RNA signature for predicting survival and immune checkpoint blockade in hepatocellular carcinoma.
Zhang Y; Zhang L; Xu Y; Wu X; Zhou Y; Mo J
J Cell Physiol; 2020 Dec; 235(12):9304-9316. PubMed ID: 32330311
[TBL] [Abstract][Full Text] [Related]
17. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
[TBL] [Abstract][Full Text] [Related]
18. Identification of chromatin organization-related gene signature for hepatocellular carcinoma prognosis and predicting immunotherapy response.
Chen J; Chen X; Li T; Wang L; Lin G
Int Immunopharmacol; 2022 Aug; 109():108866. PubMed ID: 35691273
[TBL] [Abstract][Full Text] [Related]
19. STAG Mutations in Cancer.
Romero-Pérez L; Surdez D; Brunet E; Delattre O; Grünewald TGP
Trends Cancer; 2019 Aug; 5(8):506-520. PubMed ID: 31421907
[TBL] [Abstract][Full Text] [Related]
20. Identification of immune-related lncRNA signature for predicting immune checkpoint blockade and prognosis in hepatocellular carcinoma.
Xu Q; Wang Y; Huang W
Int Immunopharmacol; 2021 Mar; 92():107333. PubMed ID: 33486322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
